Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Negotiating the maze of biotech "tool patents"

Abstract

Circumventing existing patents may be a shortcut to getting your recombinant protein to market.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: To avoid linking a bacterial promoter to a foreign gene on a plasmid, the promoter and gene are cloned separately, then combined in vitro to form a DNA circle.

References

  1. Zhang, Y. et al. 1998. Protein Expr. Purif. 12: 159–165.

    Article  Google Scholar 

  2. LaVallie, E.R. et al. 1993. Bio/Technology 11: 189–193.

    Google Scholar 

  3. Olson, P. et al. 1998. Protein Expr. Purif. 14: 160–166.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Desmond Mascarenhas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mascarenhas, D. Negotiating the maze of biotech "tool patents". Nat Biotechnol 16, 1371–1372 (1998). https://doi.org/10.1038/4357

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/4357

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing